AgingResearch.News

Osteoarthritis

Disease6 papers7 findingsMeSH D010003

In human bone marrow mesenchymal stem cells, osteoarthritis is linked to altered mtDNA copy number and heteroplasmy, whilst an in silico study associates it with meniscus WEE1, CDK6, and CDKN1A expression. Reviews describe impaired stem cells and induction by lipid metabolism.

  • Humans1
  • Animals1
  • Cells2

Effects

1

Mesenchymal stem cell

downin reviews1

1 study
  1. Osteoarthritis impairs mesenchymal stem cell.

    Review

    Clinical Translation of Mesenchymal Stem Cells to Medicinal Signaling Cells: Origins, Clinical Applications, and the Future of Regenerative Medicine-2026 Arnold I. Caplan Award for Distinguished Research in Orthobiologics · The Journal of the American Academy of Orthopaedic Surgeons · 30 Sep 2026

Upstream

1

Lipid and ceramide metabolism

upin reviews1

1 study
  1. Lipid and ceramide metabolism induces osteoarthritis.

    Reviewfor certain cholesterol and fatty acid pathwaysjoint

    Lipid Networks in Osteoarthritis: Context-Dependent Drivers, Hallmarks of Aging, and Clinical Translation · Aging and disease · 23 Sep 2026

Lipid and ceramide metabolism →

Associations

5

mtDNA copy number

downin human cells1

1 study
  1. Osteoarthritis is associated with mtDNA copy number in human cells.

    “OA-derived MSCs exhibited a markedly increased heteroplasmic burden, followed by decrease in mtDNA copy number”

    Cellsbone marrow mesenchymal stem cell

    Characterization of the Mitochondrial Genome Landscape in MSCs, iPSCs and iMSCs from Osteoarthritis Patients and Healthy Donors · Genes · 11 Sep 2026

mtDNA copy number →

mtDNA heteroplasmy

upin human cells1

1 study
  1. Osteoarthritis is associated with mtDNA heteroplasmy in human cells.

    “OA-derived MSCs exhibited a markedly increased heteroplasmic burden, followed by decrease in mtDNA copy number and accumulation of non-synonymous variants”

    Cellsbone marrow mesenchymal stem cell

    Characterization of the Mitochondrial Genome Landscape in MSCs, iPSCs and iMSCs from Osteoarthritis Patients and Healthy Donors · Genes · 11 Sep 2026

mtDNA heteroplasmy →

WEE1

downin silico1

1 study
  1. Osteoarthritis is associated with WEE1 in silico (AUC 0.792).

    “CDKN1A, CDK6, and WEE1 were reduced in OA-associated meniscal samples in GSE98918; within-dataset ROC analyses yielded AUCs of 0.931, 0.882, and 0.792, respectively.”

    In silicomeniscus

    Senescence-Associated Checkpoint Gene Dysregulation in Established Osteoarthritis: Integrated Transcriptomic Analysis and In Vitro Evaluation of CDK6 and WEE1 · Biomedicines · 26 Aug 2026

WEE1 →

CDK6

downin silico1

1 study
  1. Osteoarthritis is associated with CDK6 in silico (AUC 0.882).

    “CDKN1A, CDK6, and WEE1 were reduced in OA-associated meniscal samples in GSE98918; within-dataset ROC analyses yielded AUCs of 0.931, 0.882, and 0.792, respectively.”

    In silicomeniscus

    Senescence-Associated Checkpoint Gene Dysregulation in Established Osteoarthritis: Integrated Transcriptomic Analysis and In Vitro Evaluation of CDK6 and WEE1 · Biomedicines · 26 Aug 2026

CDK6 →

CDKN1A

downin silico1

1 study
  1. Osteoarthritis is associated with CDKN1A in silico (AUC 0.931).

    “CDKN1A, CDK6, and WEE1 were reduced in OA-associated meniscal samples in GSE98918; within-dataset ROC analyses yielded AUCs of 0.931, 0.882, and 0.792, respectively.”

    In silicomeniscus

    Senescence-Associated Checkpoint Gene Dysregulation in Established Osteoarthritis: Integrated Transcriptomic Analysis and In Vitro Evaluation of CDK6 and WEE1 · Biomedicines · 26 Aug 2026

CDKN1A →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 6Oct 2026: 07